Antibiotic Prophylaxis Before Simple Tooth Extraction in Immunosuppressed Patients with Autoimmune Rheumatic Diseases
Official title: Effectiveness of Short-Course Antibiotic Prophylaxis After Simple Tooth Extraction in Immunosuppressed Patients With Autoimmune Rheumatic Diseases
Run by University of Sao Paulo General Hospital · NCT07275580 · Data updated 2026-11-12
This trial tests whether giving a single dose of amoxicillin before a simple tooth extraction can prevent infections in adults with autoimmune rheumatic diseases who are on immunosuppressive therapy.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 352 (estimated) |
| Sponsor | University of Sao Paulo General Hospital Academic / other |
| Drugs / interventions | denosumab, radiation, methotrexate, cyclophosphamide, prednisone |
| Locations | 1 site (São Paulo, São Paulo) |
| Status | Recruiting |
| Started | October 7, 2026 |
| Main results expected | June 1, 2029 |
| Study ends | December 30, 2029 |
| Registry record updated | October 15, 2026 |
| Trial ID | NCT07275580 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with an autoimmune rheumatic disease on immunosuppressive therapy who require a simple tooth extraction and have no current infection requiring antibiotics, and who can provide informed consent.
✕Probably not a fit
Patients not on immunosuppressive therapy, those undergoing complex or multiple extractions, or those with active infections or contraindications to antibiotics may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, double-blind, placebo-controlled Phase 4 trial evaluating the need for antibiotic prophylaxis before simple tooth extractions in adults with autoimmune rheumatic diseases who are immunosuppressed. Participants receive either amoxicillin or placebo prior to extraction, and postoperative infection rates, infection severity, and other complications are monitored. The study also explores how the type of ARD and immunosuppressive treatment may influence infection risk. The trial aims to provide evidence to guide antibiotic stewardship in this specific patient population.
Why it matters
Potential benefit: If successful, the trial could reduce unnecessary antibiotic use and associated risks while maintaining protection against postoperative infections in immunosuppressed ARD patients.
How similar studies have gone: Previous studies in immunocompromised populations suggest antibiotics may not always be necessary for simple extractions, but this is the first prospective, randomized trial focused on ARD patients.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years * Confirmed diagnosis of an ARD: SLE, RA, JIA, AS, PsA, IIM, systemic vasculitis, primary Sjögren's syndrome, or SSc * Use of prednisone and/or at least one synthetic immunosuppressant (methotrexate, azathioprine, mycophenolate mofetil, leflunomide, cyclophosphamide, cyclosporine, or tacrolimus), immunobiological agent or immunomodulator (chloroquine, sulfasalazine), with no plans to switch medications. * Indication for simple tooth extraction with chronic odontogenic focus * Provided informed consent Exclusion Criteria: * Individuals who do not agree to participate in the study will be excluded. * Patients requiring extractions that are more complex from a technical standpoint, such as impacted third molars. * Patients with local or systemic conditions requiring more extensive antibiotic coverage, such as cases with clinical signs of acute infections, patients on anticoagulant therapy, patients with heart disease, patients who have undergone radiation therapy, or patients currently being treated for neoplasms; * Patients allergic to amoxicillin. * Patients currently receiving any antibiotic prophylaxis or treatment; * Patients who have undergone corticosteroid pulse therapy within the last month; * Patients taking drugs with antiresorptive effects on bone, such as oral or injectable bisphosphonates and denosumab.
Where it's running
-
Rheumatology Division, Faculdade de Medicina da USP, São Paulo, SP, São Paulo, Sao paulo 01246-903
São Paulo, São Paulo, Brazil Recruiting
Study contacts
- Principal investigator: Eloisa Bonfá, Full Professor — Hospital das Clínicas da Faculdade de Medicina da USP - HCFMUSP
- Study coordinator: Eloisa Bonfá, Full Professor
- Email: eloisa.bonfa@hc.fm.usp.br
- Phone: +55 11 30617492
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Which single-dose antibiotic works best to prevent complications after lower wisdom tooth removal
This trial tests whether a single dose of amoxicillin, clindamycin, or azithromycin is best at reducing post-surgery problems for adults undergoing lower wisdom tooth extraction.
-
Curcumin topical spray for healing after a first molar extraction
This study tests whether a curcumin spray applied to the extraction site helps healing and reduces pain compared with chlorhexidine spray or standard care in healthy adults undergoing a first molar extraction.
-
Effect of four post-extraction socket approaches on preserving the ridge after tooth removal
This study tests four ways to care for an extraction socket to see which best preserves the jawbone and gum after tooth removal for future implants.
-
Thymoquinone 0.2% Gel to Protect Bone After Tooth Extraction
A gel with 0.2% thymoquinone is tested to see if it helps keep bone density and width after pulling a back upper tooth in adults.
-
Beta-Tricalcium Phosphate for preserving the ridge after tooth extraction
This early-phase trial tests whether beta-tricalcium phosphate helps preserve bone volume after tooth extraction compared with natural healing.
-
Ridge Preservation With Collagen Membrane After Tooth Extraction
This study tests whether adding a resorbable collagen membrane to a bone graft improves jawbone preservation after tooth extraction for people who have significant buccal bone loss.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.